How Pfizer Won the Pandemic, Reaping Outsize Profit and Influence
The drugmaker has the best-selling vaccine to prevent covid and the most effective drug to treat it. Its success has overshadowed the government鈥檚 covid-fighting strategy.
The independent source for health policy research, polling, and news.
281 - 300 of 819 Results
The drugmaker has the best-selling vaccine to prevent covid and the most effective drug to treat it. Its success has overshadowed the government鈥檚 covid-fighting strategy.
The Supreme Court鈥檚 decision overturning Roe v. Wade has created far more questions than it has answered about the continued legality and availability of abortion, as both abortion rights supporters and anti-abortion activists scramble to put their marks on policy. Meanwhile, Congress completes work on its gun bill and the FDA takes up the problem of the next covid-19 booster. Margot Sanger-Katz of The New York Times, Sarah Karlin-Smith of the Pink Sheet, and Victoria Knight of KHN join KHN鈥檚 Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KHN鈥檚 Angela Hart, who reported and wrote the latest KHN-NPR 鈥淏ill of the Month鈥 episode about two identical eye surgeries with very different price tags.
For now, monkeypox poses a low risk to the U.S. public, but it could become a problem if the spread is left unchecked. Here鈥檚 what everyone should know about it.
KHN gives readers a chance to comment on a recent batch of stories.
The wait is nearly over for parents of kids under 5 as a key advisory committee to the FDA recommends authorizing a covid-19 vaccine for the youngest children. Meanwhile, Congress is struggling to fill in the details of its gun control compromise, and, as the Supreme Court prepares to throw the question of abortion legality back to the states, the number of abortions has been rising. Shefali Luthra of The 19th, Sarah Karlin-Smith of the Pink Sheet, and Sandhya Raman of CQ Roll Call join KHN鈥檚 Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
One million Americans have died from covid-19 鈥 far more per capita than in any other developed country. A new variant is doubling case rates in some states, and more than 300 people are dying a day. But our nation鈥檚 pandemic response has become mild-mannered and performative, backed by neither money, urgency, nor enforcement.
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here鈥檚 a collection of their appearances.
KHN gives readers a chance to comment on a recent batch of stories.
Even in deep-blue California, Democratic lawmakers pulled their proposed covid vaccine requirements before they had a vote. The lawmakers blamed the ebbs and flows of the coronavirus, the public鈥檚 short attention span, and opposition from public safety unions.
After years of failure, the Maryland company aims to attract the vaccine-hesitant with an alternative to mRNA shots. But will it find a market?
KHN checks back in with Dr. Taison Bell to pinpoint changes in health care equity since the rollout of the covid-19 vaccines.
KHN Editor-in-Chief Elisabeth Rosenthal joins comedian Adam Conover to discuss his new Netflix series, 鈥淭he G Word,鈥 which examines the federal government's role in Americans' lives, and how it plays out in the covid era.
Meigs County in Tennessee reported one of the highest covid-19 vaccination rates in the South for much of the past year. But those reports were wrong because of a data error that has surfaced in other states, such as West Virginia and Montana, as well.
Covid cases are again climbing, but you wouldn鈥檛 know it from the behavior of public health and elected officials, much less the general public, all of whom seem to want to put the pandemic in the rearview mirror. Meanwhile, the fallout over the leaked Supreme Court draft opinion on abortion continues even as the Senate fails 鈥 again 鈥 to muster the votes to write abortion rights into law. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Alice Miranda Ollstein of Politico, and Sandhya Raman of CQ Roll Call join KHN鈥檚 Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists suggest their favorite health policy stories of the week they think you should read, too.
Approximately 1 in 3 Americans 65 and older who completed their initial vaccination round still have not received a first booster shot. The numbers dismay researchers, who say the lag has cost tens of thousands of lives.
How different are the seemingly endless stream of emerging omicron subvariants from one another and how protected are we?
Congress is back in session, but covid diagnoses for Vice President Kamala Harris and two Democratic senators have temporarily left the Senate without a working majority to approve continued covid funding. Meanwhile, opponents of the Affordable Care Act have filed yet another lawsuit challenging a portion of the law, and we say goodbye to the late Sen. Orrin Hatch of Utah, who left a long legacy of health laws. Rachel Cohrs of STAT News, Anna Edney of Bloomberg News, and Rebecca Adams of KHN join KHN鈥檚 Julie Rovner to discuss these issues and more.
Federal funding that paid for covid testing, treatment, and vaccines for uninsured people has run out. While some states struggle to make up the difference, California is relying on other state and local programs to continue free testing.
Legislators in Kansas are pushing bills to expand exemptions for school vaccines, allowing religious exemptions for all vaccine requirements in the state's schools without families having to provide any proof of their beliefs. Similar bills are being introduced around the nation as the anti-vaccine movement gains traction among politicians.
Across Los Angeles County, few people are showing up at covid vaccination drives even though nearly 2 million residents remain unvaccinated.
漏 2026 KFF